Skip to main content

Table 6 Univariate and multivariate survival analysis

From: Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer

Different variables

SULpeak

MTV

TLG

PFS

OS

PFS

OS

PFS

OS

UV

MV

UV

MV

UV

MV

UV

MV

UV

MV

UV

MV

MST

p

p

MST

p

p

MST

p

p

MST

p

p

MST

p

p

MST

p

p

Age

 < 75

168

  

NR

0.645

 

168

  

NR

  

168

  

168

  

 ≥ 75

188

0.344

 

537

  

188

0.344

 

537

0.645

 

188

0.344

 

188

0.344

 

Sex

 Male

174

  

759

  

174

  

759

  

174

  

174

  

 Female

196

0.932

 

NR

0.499

 

196

0.932

 

NR

0.499

 

196

0.932

 

196

0.932

 

PS

 0–1

239

  

NR

  

239

  

NR

  

239

  

239

  

 2

65

0.079

 

235

0.004

0.014

65

0.079

 

235

0.004

0.016

65

0.079

 

65

0.079

 

Histology

 AD

178

  

759

  

178

  

759

  

178

  

178

  

 Non-AC

205

0.889

 

396

0.447

 

205

0.889

 

396

0.447

 

205

0.889

 

205

0.889

 

RECIST

 Res

393

  

NR

  

393

  

NR

  

393

  

393

  

 NRes

174

0.494

 

759

0.908

 

174

0.494

 

759

0.908

 

174

0.494

 

174

0.494

 

 Uncontrol

105

  

NR

  

105

  

NR

  

105

  

105

  

 Control

239

0.016

0.632

539

0.807

0.741

239

0.016

0.208

539

0.807

 

239

0.016

0.935

239

0.016

0.935

irRECIST

 Res

393

  

NR

  

393

  

NR

  

393

  

393

  

 NRes

174

0.494

 

759

0.908

 

174

0.494

 

759

0.908

 

174

0.494

 

174

0.494

 

 Uncontrol

95

  

NR

  

95

  

NR

  

95

  

95

  

 Control

239

0.001

0.436

537

0.636

 

239

0.001

0.070

537

0.636

 

239

0.001

0.589

239

0.001

0.589

PERCIST

 Res

386

  

537

  

393

  

NR

  

355

  

355

  

 NRes

144

0.066

 

759

0.954

 

138

0.105

 

514

0.136

 

133

0.119

 

133

0.119

 

 Uncontrol

230

  

NR

  

108

  

371

  

105

  

105

  

 Control

178

0.705

 

537

0.459

 

566

< 0.001

0.021

NR

0.035

0.770

393

< 0.001

0.115

393

< 0.001

0.115

iPERCIST

 Res

393

  

NR

  

393

  

NR

  

355

  

355

  

 NRes

133

0.016

0.040

514

0.288

0.208

138

0.105

 

514

0.136

 

133

0.119

 

133

0.119

 

 Uncontrol

174

  

NR

  

95

  

371

  

79

  

79

  

 Control

188

0.987

 

537

0.633

 

393

< 0.001

0.761

NR

0.030

0.960

355

< 0.001

0.942

355

< 0.001

0.942

EORTC

 Res

355

  

NR

  

393

  

NR

  

393

  

393

  

 NRes

165

0.109

 

759

0.874

 

129

0.064

 

514

0.156

 

125

0.035

0.958

125

0.035

0.958

 Uncontrol

239

  

NR

  

111

  

372

  

95

  

95

  

 Control

168

0.712

 

759

0.907

 

393

0.001

0.038

NR

0.057

 

355

< 0.001

0.749

355

< 0.001

0.749

  1. Abbreviations: SULpeak The peak standardized uptake value normalized by lean body mass, MTV Metabolic tumor volume, TLG Total lesion glycolysis, PFS Progression-free survival, OS Overall survival, UV Univariate analysis, MV Multivariate analysis, MST Median survival time (days), p. P-value, PS Performance status, AD Adenocarcinoma, Non-AD Non-adenocarcinoma, Res Responder, NRes Non-responder, NR Not reached, Uncontrol Uncontrolled disease, Control Controlled disease, bold types Statistically significance